Prediction of subcutaneous drug absorption – Characterization of subcutaneous interstitial fluids as a basis for developing biorelevant in vitro models

Unlike orally administered drugs, the absorption profile of subcutaneously injectable drugs in humans is difficult to predict from preclinical studies. Since the subcutaneous interstitial fluid (ISF) is the first fluid interacting with the administered formulation before the respective drug is absorbed, it could critically affect bioavailability. The aim of the present study was to gain a better understanding of the similarities and differences of ISF of different species. For this purpose, ISF was isolated from subcutaneous tissues of five preclinical animal species, i.e., mice, rats, minipig, landrace pig, non-human primates, and humans, using a centrifugation method, and characterized with respect to its major constituents and physicochemical properties. The results show trends between animal species, with ISF from non-human primates differing significantly from that of the other preclinical species for most parameters analyzed and showing similarities to ISF of human origin. Although from a statistical point of view it will be necessary to further increase the existing data sets, the presented data provide valuable information for the development of biorelevant in vitro models to predict the in vivo performance of subcutaneously administered formulations, as they provide fundamental information for the design of biorelevant ISF media for both preclinical species and humans.

Read more

Iria Torres-Terán, Márta Venczel, Tatjana Stieler, Laura Parisi, Alla Kloss, Sandra Klein, Prediction of subcutaneous drug absorption – Characterization of subcutaneous interstitial fluids as a basis for developing biorelevant in vitro models, International Journal of Pharmaceutics, Volume 638, 2023, 122906, ISSN 0378-5173,
https://doi.org/10.1016/j.ijpharm.2023.122906.